About 4,270,000 results
Open links in new tab
Amgen's Uplizna posts strong results in myasthenia gravis trial
Inebilizumab Improved Outcomes Over Placebo in Phase 3 Trials …
Potential Regulatory Submission for Inebilizumab in Myasthenia …
Positive new phase 3 MRI data from UPLIZNA trial for NMOSD
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 …
Amgen preps Uplizna filing for a second indication
FDA Approves New Therapy for Rare Disease Affecting Optic …
Uplizna Treatment for NMOSD Shows Sustained Clinical Benefit …
MITIGATE: Inebilizumab Reduces Risk of IgG4-Related Disease Flare
Amgen's Uplizna proves its worth in another rare disease, setting …
- Some results have been removed